Vaccines
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
Following successful Phase 3 trial results, mRNA platforms are emerging as a versatile, rapid tool for training the immune system to target…
-
Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk 42% in Late-Stage Trial
Discover how custom mRNA cancer vaccines train the immune system against tumor neoantigens to prevent melanoma recurrence compared to standard adjuvant therapy.
-
Uganda Trial: One-Fifth Yellow Fever Dose Works in Children
KAMPALA, September 13 — A clinical trial in Uganda has found that a one-fifth dose of yellow fever vaccine protected children under…
-
Ebola Bundibugyo Outbreak in DR Congo Reaches Eight Provinces, WHO Says
Mbandaka, August 20 — The Democratic Republic of the Congo faces a resurgent Ebola outbreak that health authorities are struggling to contain,…
-
US Childhood Vaccine Hesitancy and Falling Coverage Raise Risk of Measles Outbreaks
MANILA, July 21 — Vaccine hesitancy — a delay in accepting or refusing vaccines despite their availability and proven effectiveness — has…
-
How Vaccines Train the Immune System and Cut Deaths from Disease
ASTANA, July 14 — The global vaccine market, a sector that directly shapes public health outcomes from Central Asia to the Americas,…
-
Innate vs. Adaptive Immunity: Two-Layered Defense System
MANILA, July 14 — For families across Asia, the idea of being protected from a disease long after recovery is something many…
-
Vaccine Development Timeline: From 1796 to mRNA in 2020
ROME, July 14 — For families, the story of vaccines is not a dry list of dates and laboratories. It is the…
-
Experimental vaccine shields mice from fentanyl and its chemical relatives
WASHINGTON — Inside a laboratory, a small group of mice is changing how researchers think about the opioid crisis. These animals, immunized…
-
Scripps Chemist Develops Vaccine To Train Immune System Against Fentanyl
LA JOLLA — Dr. Kim D. Janda is working on a vaccine that could change how the country fights the fentanyl crisis.…
-
Fentanyl Vaccine That Keeps the Drug Out of the Brain Is Set for Human Trials
ISLAMABAD, July 13 — A vaccine candidate designed to block fentanyl from reaching the brain has completed preclinical studies in animals, with…
-
University of Houston Fentanyl Vaccine Targets Drug’s Chemical Backbone
HOUSTON, July 13 — A novel vaccine candidate developed at the University of Houston is targeting the chemical backbone of fentanyl and…
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
-
Katalin Karikó’s mRNA research wins 2023 Nobel Prize
LONDON, July 10 — The detail that matters in the story of Katalin Karikó is not the Nobel Prize, nor the 95%…
-
Decades of mRNA Research Led to Fastest Vaccines by 2020
ROME, July 10 — The story of messenger RNA vaccines begins not in a pandemic, but in a laboratory mouse. In 1990,…
-
Vaccination’s Journey: From Ancient Variolation to Modern Immunization
ROME, July 10 — The record of vaccination begins with a single act in 1796, when English physician Edward Jenner used material…
-
Immunization Prevents 3.5 Million to 5 Million Deaths a Year, WHO Says, but Coverage Gaps Persist
GENEVA, July 8 — The World Health Organization estimates that immunization prevents 2-3 million deaths every year from diseases including diphtheria, tetanus,…
-
Personalized Vaccine Plus Immunotherapy Shows Promise in Advanced Head and Neck Cancer
NEW YORK, July 5, 2026 — For families facing a cancer diagnosis, the word “immunotherapy” has become a beacon of hope. The…
-
AI-designed vaccine passes first human trial, targets multiple coronaviruses
/ HTML. So we can have headings and paragraphs . Must not add new info. Must keep facts: AI-designed vaccine from University…
-
AI-Designed Universal Coronavirus Vaccine Passes First Human Trial
SOUTHAMPTON, June 5 — Researchers at the University of Cambridge and their spinout DIOSynVax have completed the first human trial of a…
-
University of Kent Meningitis Outbreak Kills 2, Hospitalizes 11
Canterbury, Kent, England, March 15, 2026 — infopulsetoday.com — A meningitis outbreak at the University of Kent in Canterbury, Kent, England has…
-
England Begins World-First Gonorrhoea Vaccine Rollout in Sexual Health Clinics
NHS England is preparing to introduce a vaccination programme targeting gonorrhea, scheduled to begin in August. This initiative is described as the…
-
Moderna’s New mNEXSPIKE COVID-19 Vaccine Wins FDA Approval After Phase 3 Trial
The Moderna COVID-19 vaccine, also known as Spikevax, has been a crucial tool in the fight against COVID-19, a disease caused by…
-
West Texas Measles Outbreak Reaches 146 Cases After a Child’s Death
As of February 28, 2025, Texas health officials have recorded 146 confirmed measles infections spread across nine counties, with twenty of those…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























